The Biozentrum of the University of Basel is one of the worldwide leading institutes for molecular and biomedical basic research and teaching.

In its research, the Biozentrum incorporates the benefits of being international, interdisciplinary and innovative along with having leading-edge technology and highly qualified and motivated employees.

In the training of top qualified scientists for the future to work in universities, industry and the community, the Biozentrum emphasizes a strong research orientation and the close guidance of its students.

Michael N. Hall awarded Cancer Research Prize

On February 8th, 2017, the American National Foundation for Cancer Research announced that Michael N. Hall, Professor of Biochemistry at the Biozentrum of the University of Basel, has been selected as the winner of the 2017 Szent-Györgyi Prize for Progress in Cancer Research. The award recognizes his groundbreaking discovery of the protein kinase... more

Not necessarily harmful: Protein aggregates in the brain

Protein aggregates in neurons are characteristic for Alzheimer's, Parkinson's and other neurodegenerative diseases. These so-called amyloids arise from misfolded proteins and lead to cell death. The team headed by Prof. Martin Spiess at the Biozentrum of the University of Basel has demonstrated by the example of the hormone vasopressin that such... more

Silvia Arber receives the 2017 Louis-Jeantet Prize for Medicine

The 2017 Louis-Jeantet Prize for Medicine is awarded to Silvia Arber, Professor of Neurobiology at the Biozentrum, University of Basel, and senior group leader at the Friedrich Miescher Institute (FMI) in Basel, and to the immunologist Caetano Reis e Sousa, senior group leader at The Francis Crick Institute, United Kingdom. The award ceremony will... more